Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables - Net (2023 - 2025)

Historic Receivables - Net for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $515000.0.

  • CG Oncology's Receivables - Net rose 27591.24% to $515000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 27591.24%. This contributed to the annual value of $92000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Receivables - Net is $515000.0, which was up 27591.24% from $562000.0 recorded in Q2 2025.
  • CG Oncology's Receivables - Net's 5-year high stood at $562000.0 during Q2 2025, with a 5-year trough of $92000.0 in Q4 2023.
  • Moreover, its 3-year median value for Receivables - Net was $182000.0 (2024), whereas its average is $283714.3.
  • The largest annual percentage gain for CG Oncology's Receivables - Net in the last 5 years was 27591.24% (2025), contrasted with its biggest fall of 12549.02% (2025).
  • Over the past 3 years, CG Oncology's Receivables - Net (Quarter) stood at $92000.0 in 2023, then skyrocketed by 48.91% to $137000.0 in 2024, then soared by 275.91% to $515000.0 in 2025.
  • Its last three reported values are $515000.0 in Q3 2025, $562000.0 for Q2 2025, and $345000.0 during Q1 2025.